UnitedHealth Group Incorporated

GRI Bio, Inc.

Cartesian Therapeutics, Inc.

Viridian Therapeutics, Inc.

Jazz Pharmaceuticals plc

Compass Therapeutics, Inc.

SpyGlass Pharma, Inc.

Summit Therapeutics Inc.

Generate Biomedicines, Inc.

Congress: 3 buys, 1 sells (50 total trades)

INTELLIGENT CROSS LLC

UBS ATS

BNPP CORTEX ATS

LEVEL ATS

Dilution score: 9/100 (LOW), 999.0 months cash

13F fund flow: neutral, 71 institutional managers

Viking Global

Senator Inv Group

Bridgewater

Winton

Pentwater

Hudson Bay

Owl Creek

Element Capital

Capital Research

10 PubMed publications found for UnitedHealth  Incorporated

The long-term effectiveness of the anti-obesity medication phentermine (LEAP) trial: Rationale, design, and baseline characteristics.

Association of Assisted Reproductive Technology and Stroke During Hospitalization for Delivery in the United States.

Uncontrolled Extensions of Clinical Trials and the Use of External Controls-Scoping Opportunities and Methods.

Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus.

Incorporating Present-on-Admission Indicators in Medicare Claims to Inform Hospital Quality Measure Risk Adjustment Models.

Short interest: 2.03% of float, squeeze risk: LOW

SW convergence: 46/100 (Neutral), 1 bullish / 2 bearish signals

<article class="bts-verified-summary" data-ticker="UNH">
<p>UnitedHealth Group Incorporated Common Stock (DE) (UNH) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>UNH has 25 Form 4 insider filings recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0000731766 (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22UNH%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>

UnitedHealth Group Incorporated Common Stock (DE)

SEC EDGAR — 0000731766

UnitedHealth Group Incorporated Common Stock (DE) (UNH) — BioTechSigns Verified Summary

UnitedHealth Group Incorporated Common Stock (DE) (UNH) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

UNH has 25 Form 4 insider filings recorded at the SEC in the past 30 days[1].

Sources:
[1] SEC EDGAR, 0000731766. Source last updated 2026-04-11, retrieved 2026-04-11.
    https://efts.sec.gov/LATEST/search-index?q=%22UNH%22&forms=4&dateRange=custom&startdt=2026-03-12&enddt=2026-04-11